Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03386812 · ClinicalTrials.gov registry record
Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 19
- Enrollment target
NCT03386812: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT03386812 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03386812 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The overall goal of this pilot project is to test the hypothesis that a decline in muscle strength precedes the decline in bone strength in men undergoing androgen deprivation therapy (ADT) for prostate cancer. The investigators will measure changes in serum biomarkers involved in muscle-bone crosstalk, anatomic changes in muscle and bone structure and strength that could ultimately contribute to fractures. The findings from this research will inform design of interventions to reduce falls and hip fractures in patients undergoing ADT as well as application to broader populations of at risk patients.
Primary Outcome
Absolute muscle fat concentration (% proton density fat fraction) following ADT therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2020-11-29 |
What the finished NCT03386812 record still lists
NCT03386812 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03386812 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03386812 about?
NCT03386812 is a clinical study titled "Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer". The overall goal of this pilot project is to test the hypothesis that a decline in muscle strength precedes the decline in bone strength in men undergoing androgen deprivation therapy (ADT) for prostate cancer. The investigators will measure changes in serum biomarkers involved in muscle-bone crosst...
What is the current status of trial NCT03386812?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2017-10-01. Estimated completion is 2020-11-29.
Who is sponsoring clinical trial NCT03386812?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI